N
NextCell Pharma AB
STO:NXTCL
NextCell Pharma AB
STO:NXTCL
Price:
1.266
SEK
-4.52%
Market Cap:
kr141m
Wall Street
Price Targets
NXTCL Price Targets Summary
NextCell Pharma AB
NextCell Pharma AB
Wall Street analysts forecast NXTCL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.535 SEK and a high forecast of 3.675 SEK.
Lowest
Price Target
3.535
SEK
179% Upside
Average
Price Target
3.57
SEK
182% Upside
Highest
Price Target
3.675
SEK
190% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NXTCL's stock price target?
Price Target
3.57
SEK
3.57
SEK
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.535 SEK and a high forecast of 3.675 SEK.
What is NextCell Pharma AB's Revenue forecast?
Projected CAGR
429%
429%
For the last 9 years the compound annual growth rate for NextCell Pharma AB's revenue is 34%. The projected CAGR for the next 2 years is 429%.
